References

  1. J.Y. Choi, D.H. Han, Y.K. Kim, J.H. Ahn, New permit system for management of industrial wastewater facilities, J. Korean Soc. Water Wastewater, 25 (2011) 169–170.
  2. B. Ferrari, N. Paxeus, R.L. Giudice, A. Pollio, J. Garric, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf., 55 (2003) 359–370.
  3. P.K. Jjemba, Excretion and ecotoxicity of pharmaceuticals and personal care products in the environment, Ecotoxicol. Environ. Saf., 63 (2006) 113–130.
  4. M. Grung, T. Kallqvist, S. Sakshaug, S. Skurtveit, K.V. Thomas, Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline, Ecotoxicol. Environ. Saf., 71 (2008) 328–340.
  5. T. Lin, S. Yu, W. Chen, Occurrence, removal and risk assessment of pharmaceuticals and personal care products (PPCPs) in an advanced drinking water treatment plant (ADWTP) around Taihu Lake in China, Chemosphere, 152 (2016) 1–9.
  6. A.B.A. Boxall, M.A. Rudd, B.W. Brooks, D.J. Caldwell, K. Choi, S. Hickmann, E. Innes, K. Ostapyk, J.P. Staveley, T. Verslycke, G.T. Ankley, K.F. Beazley, S.E. Belanger, J.P. Berninger, P. Carriquiriborde, A. Coors, P.C. DeLeo, S.D. Dyer, J.F. Ericson, F. Gagné, J.P. Giesy, T. Gouin, L. Hallstrom, M.V. Karlsson, D.G.J. Larsson, J.M. Lazorchak, F. Mastrocco, A. McLaughlin, M.E. McMaster, R.D. Meyerhoff, R. Moore, J.L. Parrott, J.R. Snape, R. Murray-Smith, M.R. Servos, P.K. Sibley, J.O. Straub, N.D. Szabo, E. Topp, G.R. Tetreault, V.L. Trudeau, G.V.D. Kraak, Pharmaceuticals and personal care products in the environment: what are the big questions?, Environ. Health Perspect. 120 (2012) 1221–1229.
  7. Q. Bu, B. Wang, J. Huang, S. Deng, G. Yu, Pharmaceuticals and personal care products in the aquatic environment in China: a review, J. Hazard. Mater., 262 (2013) 189–211.
  8. E. Vulliet, C. Cren-Olive, M.F. Grenier-Loustalot, Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters, Environ. Chem. Lett., 9 (2011) 103–114.
  9. M. Clara, B. Strenn, O. Gans, E. Martinez, N. Kreuzinger, H. Kroiss, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res., 39 (2005) 4797–4807.
  10. H. Sanderson, D.J. Johnson, T. Reitsma, R.A. Brain, C.J. Wilson, K.R. Solomon, Ranking and prioritization of environmental risks of pharmaceuticals in surface waters, Regul. Toxicol. Pharm., 39 (2004) 158–183.
  11. W.J. Sim, J.W. Lee, J.E. Oh, Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea, Environ. Pollut., 158 (2010) 1938–1947.
  12. S.D. Kim, J. Cho, I.S. Kim, B.J. Vanderford, S.A. Snyder, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters, Water Res., 41 (2007) 1013–1021.
  13. X. Yang, R.C. Flowers, H.S. Weinberg, P.C. Singer, Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant, Water Res., 45 (2011) 5218–5228.
  14. S.K. Behera, H.W. Kim, J.E. Oh, H.S. Park, Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea, Sci. Total Environ., 409 (2011) 4351–4360.
  15. N. Nakada, H. Shinohara, A. Murata, K. Kiri, S. Managaki, N. Sato, H. Takada, Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant, Water Res., 41 (2007) 4373–4382.
  16. J.T. Yu, E.J. Bouwer, M. Coelhan, Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent, Agric. Water Manage., 86 (2006) 72–80.
  17. A. Joss, E. Keller, A.C. Alder, A. Gobel, C.S. McArdell, T. Ternes, H. Siegrist, Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res., 39 (2005) 3139–3152.
  18. M.J. Gomez, M.J.M. Bueno, S. Lacorte, A.R. Fernandez-Alba, A. Aguera, Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast, Chemosphere, 66 (2007) 993–1002.
  19. K. Kummerer, The presence of pharmaceuticals in the environment due to human use – present knowledge and future challenges, J. Environ. Manage., 90 (2009) 2354–2366.
  20. J.C. Madden, S.J. Enoch, M. Hewitt, M.T.D. Cronin, Pharmaceuticals in the environment: good practice in predicting acute ecotoxicological effects, Toxicol. Lett., 185 (2009) 85–101.
  21. S.K. Maeng, S.K. Sharma, K.L. Teunissen, G.L. Amy, Occurrence and fate of bulk organic matter and pharmaceutically active compounds in managed aquifer recharge: a review, Water Res., 45 (2011) 3015–3033.
  22. S.A. Snyder, E.C. Wert, H. Lei, P. Westerhoff, Y.M. Yoon, Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes, AWWA Research Foundation, Denver, CO, 2007.
  23. G.T. Carroll, N.J. Turro, J.T. Koberstein, Patterning dewetting in thin polymer films by spatially directed photocrosslinking, J. Colloid Interface Sci., 351 (2010) 556–560.
  24. M. Finsgar, I. Milosev, Inhibition of copper corrosion by 1,2,3-benzotriazole: a review, Corros. Sci., 52 (2010) 2737–2749.
  25. M. Placzek, M. Dendorfer, B. Przybilla, K.P. Gilbertz, B. Eberlein, Photosensitizing properties of compounds related to benzophenone, Acta Derm. Venereol., 93 (2013) 30–32.
  26. C. Sease, Benzotriazole: a review for conservators, Stud. Conserv., 23 (1978) 76–85.
  27. D.W. Kolpin, E.T. Furlong, M.T. Meyer, E.M. Thurman, S.D. Zaugg, L.B. Barber, H.T. Buxton, Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. stream, 1999-2000: a national reconnaissance, Environ. Sci. Technol., 36 (2002) 1201–1211.
  28. Global Water Research Coalition, Development of an International Priority List of Pharmaceuticals Relevant for the Water Cycle, 2008.
  29. N.H. Tran, J. Li, J. Hu, S.L. Ong, Occurrence and suitability of pharmaceuticals and personal care products as molecular markers for raw wastewater contamination in surface water and groundwater, Environ. Sci. Pollut. Res., 21 (2014) 4727–2740.
  30. J.L. Conkle, J.R. White, C.D. Metcalfe, Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system is Southeast Louisiana, Chemosphere, 73 (2008) 1741–1748.
  31. J.L. Santos, I. Aparicio, M. Callejon, E. Alonso, Occurrence of pharmaceutically active compounds during 1-year period in wastewater from four wastewater treatment plants in Seville (Spain), J. Hazard. Mater., 164 (2009) 1509–1516.
  32. A. Daneshvar, K. Aboulfadl, L. Viglino, R. Broseus, S. Sauve, A.S.M. Humery, G.A. Weyhenmeyer, M. Prevost, Evaluating pharmaceuticals and caffeine as indicators of fecal contamination in drinking water sources of the Greater Montreal region, Chemosphere, 88 (2012) 131–139.
  33. X. Li, W. Zheng, W.R. Kelly, Occurrence and removal of pharmaceutical and hormone contaminants in rural wastewater treatment lagoons, Sci. Total Environ., 445–446 (2013) 21–28.
  34. M. Carballa, F. Omil, J.M. Lema, M. Llompart, C.G. Jares, I. Rodriguez, M. Gomez, T. Ternes, Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Res., 38 (2004) 2918–2926.
  35. M. Carballa, F. Omil, J.M. Lema, Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage, Chemosphere, 72 (2008) 1118–1123.
  36. N. Lindqvist, T. Tuhkanen, L. Kronberg, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res., 39 (2005) 2219–2228.
  37. L. Lishman, S.A. Smyth, K. Sarafin, S. Kleywegt, J. Toito, T. Pear, B. Lee, M. Servos, M. Beland, P. Seto, Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada, Sci. Total Environ., 367 (2006) 544–558.
  38. K.C. Wijekoon, J.A. Mcdonald, S.J. Khan, F.I. Hai, W.E. Price, Development of predictive framework to assess the removal of trace organic chemicals by anaerobic membrane bioreactor, Bioresour. Technol., 189 (2015) 391–398.
  39. Q. Sui, X. Cao, S. Lu, W. Zhao, Z. Qiu, G. Yu, Occurrence source and fate of pharmaceuticals and personal care products in the groundwater: a review, Emerg. Contam., 1 (2015) 14–24.
  40. R.L. Serna, A. Jurado, E.V. Sune, J. Carrera, M. Petrovic, D. Barcelo, Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain, Environ. Pollut., 174 (2013) 305–315.
  41. B. Morasch, Occurrence and dynamics of micropollutants in a karst aquifer, Environ. Pollut., 173 (2013) 133–137
  42. Y. Cabeza, L. Candela, D. Ronen, G. Teijon, Monitoring the occurrence of emerging contaminants in treated wastewater and groundwater between 2008 and 2010. The baix Llobregat (Barcelona, Spain), J. Hazard. Mater., 239–240 (2012) 32–39.
  43. L.A. Schaider, R.A. Rudel, J.M. Ackerman, S.C. Dunagan, J.G. Brody, Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer, Sci. Total Environ., 468– 469 (2014) 384–393.
  44. M. Petrovic, B. Skrbic, J. Zivancev, L.F. Climent, D. Barcelo, Determination of 81 pharmaceuticals drug by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole-linear ion trap in different types of water in Serbia, Sci. Total Environ., 468–469 (2014) 415–428
  45. P.M. Thomas, G.D. Foster, Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process, Environ. Toxicol. Chem., 24 (2005) 25–30.
  46. T. Okuda, Y. Kobayashi, R. Nagao, N. Yamashita, H. Tanaka, S. Tanaka, S. Fujii, C. Konishi, I. Houwa, Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan, Water Sci. Technol., 57 (2008) 65–71.
  47. M.H. Valsero, C.R. Contreras, G. Dominguez, E. Becares, J.M. Bayona, Behavior of pharmaceuticals and personal care products in constructed wetland compartment: influent, effluent, pore water, substrate and plant root, Chemosphere, 145 (2016) 508–517.
  48. B. Blair, A. Nikolaus, C. Hedman, R. Klaper, T. Crundl, Evaluating the degradation, sorption, and negative mass balances of pharmaceuticals and personal care products during wastewater treatment, Chemosphere, 134 (2015) 395–401.
  49. J. Wang, S. Wang, Removal of pharmaceuticals and personal care products (PPCPs) from wastewater: a review, J. Environ. Manage., 182 (2016) 620–640.
  50. J. Roberts, A. Kumar, J. Du, C. Hepplewhite, D.J. Ellis, A.G. Christy, S.G. Beavis, Pharmaceuticals and personal care products (PPCPs) in Australia’s largest inland sewage treatment plant, and its contribution to a major Australian river during high and low flow, Sci. Total Environ., 541 (2016) 1625–1637.
  51. N. Vieno, T. Tuhkanen, L. Krongerg, Removal of pharmaceuticals in drinking water treatment: effect of chemical coagulation, Environ. Technol., 27 (2006) 183–192.
  52. S.A. Snyder, P. Westerhoff, Y.M. Yoon, D.L. Sedlak, Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry, Environ. Eng. Sci., 20 (2004) 449–469.
  53. P. Westerhoff, Y.M. Yoon, S.A. Snyder, E. Wert, Fate of endocrine-disruptor, pharmaceuticals, and personal care product chemicals during simulated drinking water treatment processes, Environ. Sci. Technol., 39 (2005) 6649–6663.
  54. P.E. Stackelberg, J. Gibs, E.T. Furlong, M.T. Meyer, S.D. Zaugg, R.L. Lippincott, Efficiency of conventional drinking-water treatment processes in removal of pharmaceuticals and other organic compounds, Sci. Total Environ., 377 (2008) 255–272.
  55. N. Vieno, T. Tuhkanen, L. Krongerg, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res., 41 (2007) 1001–1012.
  56. R. Renner, The Kow controversy, Environ. Sci. Technol., 36 (2002) 411–413.
  57. Y.S. Liu, G.G. Ying, A. Shareef, R. Kookana, Photolysis of benzotriazole and formation of its polymerized photoproducts in aqueous solutions under UV irradiation, Environ. Chem., 8 (2010) 174–181.
  58. S. Yan, W. Song, Photo-transformation of pharmaceutically active compounds in the aqueous environment: a review, Environ. Sci. Process. Impacts, 16 (2014) 697–720.
  59. B. Yao, L. Lian, W. Pang, D. Yin, S. Chan, W. Song, Determination of illicit drugs in aqueous environmental samples by online solid-phase extraction coupled to liquid chromatographytandem mass spectrometry, Chemosphere, 160 (2016) 208–215.